Since the genes that encode the pro-apoptotic proteins PUMA and NOXA are both direct transcriptional targets of TRP53, it was hypothesised that mice lacking PUMA and NOXA (and therefore lacking the capability to undergo TRP53-mediated apoptosis) would develop tumours at the same rate as TRP53-deficient mice. The gene discussed is TP53; the disease is neoplasm.